GILD
Price
$111.06
Change
-$0.71 (-0.64%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
90.79B
28 days until earnings call
JNJ
Price
$155.79
Change
+$0.52 (+0.33%)
Updated
Jul 8, 04:59 PM (EDT)
Capitalization
380.22B
8 days until earnings call
Interact to see
Advertisement

GILD vs JNJ

Header iconGILD vs JNJ Comparison
Open Charts GILD vs JNJBanner chart's image
Gilead Sciences
Price$111.06
Change-$0.71 (-0.64%)
Volume$61.27K
Capitalization90.79B
Johnson & Johnson
Price$155.79
Change+$0.52 (+0.33%)
Volume$62.45K
Capitalization380.22B
GILD vs JNJ Comparison Chart in %
Loading...
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GILD vs. JNJ commentary
Jul 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GILD is a Buy and JNJ is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 09, 2025
Stock price -- (GILD: $111.06 vs. JNJ: $155.79)
Brand notoriety: GILD and JNJ are both notable
Both companies represent the Pharmaceuticals: Major industry
Current volume relative to the 65-day Moving Average: GILD: 56% vs. JNJ: 84%
Market capitalization -- GILD: $90.79B vs. JNJ: $380.22B
GILD [@Pharmaceuticals: Major] is valued at $90.79B. JNJ’s [@Pharmaceuticals: Major] market capitalization is $380.22B. The market cap for tickers in the [@Pharmaceuticals: Major] industry ranges from $739.66B to $0. The average market capitalization across the [@Pharmaceuticals: Major] industry is $86.34B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GILD’s FA Score shows that 4 FA rating(s) are green whileJNJ’s FA Score has 2 green FA rating(s).

  • GILD’s FA Score: 4 green, 1 red.
  • JNJ’s FA Score: 2 green, 3 red.
According to our system of comparison, both GILD and JNJ are a good buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GILD’s TA Score shows that 4 TA indicator(s) are bullish while JNJ’s TA Score has 7 bullish TA indicator(s).

  • GILD’s TA Score: 4 bullish, 3 bearish.
  • JNJ’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, JNJ is a better buy in the short-term than GILD.

Price Growth

GILD (@Pharmaceuticals: Major) experienced а -0.60% price change this week, while JNJ (@Pharmaceuticals: Major) price change was -0.08% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Major industry was -0.67%. For the same industry, the average monthly price growth was +0.29%, and the average quarterly price growth was +8.76%.

Reported Earning Dates

GILD is expected to report earnings on Oct 23, 2025.

JNJ is expected to report earnings on Oct 21, 2025.

Industries' Descriptions

@Pharmaceuticals: Major (-0.67% weekly)

The Major Pharmaceuticals industry includes companies that are involved in various processes of creating drugs to treat/prevent diseases. These companies engage in research, testing and manufacturing, as well as the distribution of pharmaceuticals into markets. Johnson & Johnson, Merck & Co., Inc., Pfizer Inc. and Novartis are among the largest companies in this category.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
JNJ($380B) has a higher market cap than GILD($90.8B). JNJ has higher P/E ratio than GILD: JNJ (30.34) vs GILD (16.20). GILD YTD gains are higher at: 22.728 vs. JNJ (9.151). JNJ has higher annual earnings (EBITDA): 23.3B vs. GILD (10.5B). JNJ has more cash in the bank: 22.9B vs. GILD (7.26B). GILD has less debt than JNJ: GILD (25B) vs JNJ (29.3B). JNJ has higher revenues than GILD: JNJ (85.2B) vs GILD (27.1B).
GILDJNJGILD / JNJ
Capitalization90.8B380B24%
EBITDA10.5B23.3B45%
Gain YTD22.7289.151248%
P/E Ratio16.2030.3453%
Revenue27.1B85.2B32%
Total Cash7.26B22.9B32%
Total Debt25B29.3B85%
FUNDAMENTALS RATINGS
GILD vs JNJ: Fundamental Ratings
GILD
JNJ
OUTLOOK RATING
1..100
2413
VALUATION
overvalued / fair valued / undervalued
1..100
20
Undervalued
18
Undervalued
PROFIT vs RISK RATING
1..100
1543
SMR RATING
1..100
2933
PRICE GROWTH RATING
1..100
2039
P/E GROWTH RATING
1..100
10079
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

JNJ's Valuation (18) in the Pharmaceuticals Major industry is in the same range as GILD (20) in the Biotechnology industry. This means that JNJ’s stock grew similarly to GILD’s over the last 12 months.

GILD's Profit vs Risk Rating (15) in the Biotechnology industry is in the same range as JNJ (43) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

GILD's SMR Rating (29) in the Biotechnology industry is in the same range as JNJ (33) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

GILD's Price Growth Rating (20) in the Biotechnology industry is in the same range as JNJ (39) in the Pharmaceuticals Major industry. This means that GILD’s stock grew similarly to JNJ’s over the last 12 months.

JNJ's P/E Growth Rating (79) in the Pharmaceuticals Major industry is in the same range as GILD (100) in the Biotechnology industry. This means that JNJ’s stock grew similarly to GILD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GILDJNJ
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
53%
Bearish Trend 2 days ago
44%
Momentum
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
39%
MACD
ODDS (%)
Bullish Trend 2 days ago
69%
Bullish Trend 2 days ago
37%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
56%
Bullish Trend 2 days ago
40%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
60%
Bullish Trend 2 days ago
39%
Advances
ODDS (%)
Bullish Trend 2 days ago
58%
Bullish Trend 8 days ago
40%
Declines
ODDS (%)
Bearish Trend 28 days ago
51%
Bearish Trend 19 days ago
43%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
53%
Bullish Trend 2 days ago
49%
Aroon
ODDS (%)
Bullish Trend 2 days ago
53%
Bullish Trend 2 days ago
33%
View a ticker or compare two or three
Interact to see
Advertisement
GILD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
JNJ
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
FTWO36.020.06
+0.18%
Strive Natural Resources and SecurityETF
NOCT54.500.08
+0.15%
Innovator Growth-100 Pwr Buff ETF™ Oct
RMNY23.98N/A
N/A
Rockefeller New York Municipal Bond ETF
EZU59.27-0.34
-0.57%
iShares MSCI Eurozone ETF
IGE44.95-0.27
-0.60%
iShares North American Natural Res ETF

JNJ and

Correlation & Price change

A.I.dvisor indicates that over the last year, JNJ has been loosely correlated with PFE. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if JNJ jumps, then PFE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To JNJ
1D Price
Change %
JNJ100%
-0.47%
PFE - JNJ
59%
Loosely correlated
-0.55%
NVS - JNJ
56%
Loosely correlated
+0.18%
GSK - JNJ
52%
Loosely correlated
+0.03%
AMGN - JNJ
44%
Loosely correlated
-1.77%
ABBV - JNJ
43%
Loosely correlated
-0.87%
More